Kidney Disease in Dogs: Stages, Signs, and Prognosis

• IRIS staging is the globally accepted system veterinarians use to describe CKD severity.
• Four stages are defined by blood creatinine and SDMA values measured in a stable, hydrated dog.
• Each stage also has substages for proteinuria (protein in urine) and blood pressure.
• Symptoms alone cannot assign an IRIS stage — laboratory values are required.
• Stage does not equal prognosis. Two dogs in the same stage can have very different outcomes depending on the underlying cause, rate of progression, and response to management.
• Laboratory reference intervals vary, and staging is a veterinary judgment that integrates multiple data points.

The IRIS staging system uses stable-state blood markers — primarily creatinine and SDMA — to classify CKD from Stage 1 (earliest, least severe) to Stage 4 (most advanced). It gives veterinarians a shared language for describing severity, choosing treatments, and tracking change over time.

Why a stable patient and confirmed CKD matter. Staging should only be done after CKD has been confirmed and the dog is adequately hydrated and clinically stable. Values drawn from a dehydrated, vomiting, or acutely ill dog may be artificially high and do not accurately reflect chronic kidney function. If your dog is ill at the time of the blood draw, your vet may recheck once the dog is stabilized before assigning a stage.

It is also important to know that the IRIS CKD staging system is not the same as acute kidney injury (AKI) grading. AKI is a sudden decline that may be reversible; CKD is a chronic, typically progressive condition. These two classifications should not be used interchangeably.

Creatinine is a waste product filtered by the kidneys. As kidney function declines, creatinine accumulates in the blood. IRIS uses specific creatinine ranges for each stage.

SDMA (symmetric dimethylarginine) is a newer biomarker that can detect kidney function loss earlier than creatinine — sometimes when only about 25 to 40 percent of function is gone. IRIS guidelines now include SDMA alongside creatinine for staging. A dog may have CKD confirmed by other evidence even when creatinine is still normal — such as persistently dilute urine, structural changes on imaging, persistent proteinuria, or an abnormal kidney biopsy.

Canine creatinine: < 1.4 mg/dL (< 125 micromol/L) SDMA: < 18 microg/dL

At Stage 1, creatinine and SDMA remain within or just at the top of normal ranges, yet there is already evidence of kidney disease — such as consistently dilute urine, kidney abnormalities on ultrasound, or persistent proteinuria. Most dogs at this stage show no obvious outward signs. Some may drink and urinate slightly more than usual, but many owners notice nothing at all.

Because symptoms are absent or minimal, Stage 1 CKD is most often caught during routine senior wellness blood work. Early detection matters: management strategies started here — dietary adjustments, hydration support, and treatment of contributing conditions — may help slow progression.

Canine creatinine: 1.4-2.8 mg/dL (125-250 micromol/L) SDMA: 18-35 microg/dL

Blood creatinine is now mildly elevated. Dogs at Stage 2 may begin showing subtle clinical signs:

• Increased thirst and urination
• Mild weight loss
• Slightly reduced appetite on some days
• Decreased coat quality

These signs can be easy to overlook or attribute to normal aging. Stage 2 is often described as an important intervention window — proactive management, including a veterinarian-guided renal diet and monitoring for proteinuria and blood pressure, can help support remaining kidney function. However, the benefit of early intervention is real but varies by individual.

Canine creatinine: 2.9-5.0 mg/dL (251-440 micromol/L) SDMA: 36-54 microg/dL

At Stage 3, azotemia (waste buildup in the blood) becomes more pronounced and clinical signs are typically noticeable:

• Persistent decreased appetite or nausea
• Vomiting episodes
• Noticeable weight and muscle loss
• Rough or dull coat
• Oral ulcers or uremic breath
• Non-regenerative anemia (pale gums, low energy)
• Increased tendency toward dehydration

Management intensifies. Depending on the individual dog's lab work and clinical picture, the veterinarian may recommend a renal-specific diet, phosphorus binders, anti-nausea medication, subcutaneous fluids at home, antihypertensives, or erythropoiesis-stimulating agents. The specific combination is tailored to the dog — there is no single standard Stage 3 treatment protocol.

Canine creatinine: > 5.0 mg/dL (> 440 micromol/L) SDMA: > 54 microg/dL

Stage 4 represents advanced CKD. Many dogs at this stage develop signs of uremic syndrome:

• Severe appetite loss or complete food refusal
• Frequent vomiting
• Marked weakness and lethargy
• Severe anemia
• Metabolic acidosis
• Electrolyte disturbances (especially potassium and phosphorus imbalance)

Some dogs may also develop neurological signs such as tremors or, less commonly, seizures.

Not every Stage 4 dog shows every symptom listed above — the clinical picture varies. The focus of care shifts toward maintaining comfort and quality of life, with close veterinary guidance.

When kidney disease reaches the point where medical management can no longer keep the animal comfortable, end-of-life discussions become part of the care plan. Signs that quality of life is declining may include uncontrollable nausea, refusal to eat or drink, severe weakness, and progressive weight loss despite treatment. Your veterinarian can help you assess your dog's comfort and guide decisions about hospice care or humane euthanasia. For more on this topic, see end-stage kidney disease.

IRIS staging does not stop at the creatinine/SDMA-based stage number. Two additional substages refine the picture and change management decisions:

Proteinuria substaging (based on urine protein-to-creatinine ratio, UPC):

Proteinuria indicates ongoing kidney damage and is an independent risk factor for progression. Dogs classified as proteinuric typically benefit from treatment to reduce protein loss.

Blood pressure substaging:

High blood pressure accelerates kidney damage and can injure the eyes, brain, and heart. Antihypertensive medication may be recommended depending on the substage and the presence of target-organ damage.

Both substages should be reassessed at each recheck visit because they can change independently of the creatinine-based stage.

What if creatinine and SDMA suggest different stages? This happens. SDMA can detect kidney function loss earlier than creatinine, and the two markers sometimes place a dog in different stages. When they disagree, the IRIS guidelines recommend considering the higher stage for management decisions and discussing the discrepancy with your veterinarian.

Why stage alone cannot predict life expectancy. Owners understandably want to know how long a dog at a given stage will live. The honest answer is that stage alone does not determine life expectancy. Factors that influence outcome include:

• The underlying cause of CKD (and whether it is treatable)
• The rate of creatinine and SDMA change over time
• Proteinuria and blood pressure substages
• The dog's response to dietary and medical management
• The presence of other health conditions

A Stage 2 dog with severe proteinuria and uncontrolled hypertension may decline faster than a Stage 3 dog with stable values and good dietary compliance. Published survival studies report wide ranges depending on all of these variables. Use the stage as a framework for discussion with your veterinarian, not as a countdown.

Dogs diagnosed at early stages of kidney disease — particularly Stage 1 or 2 — who receive consistent dietary management, hydration support, and regular monitoring can live comfortably for months to years in many cases. Prognosis depends on the individual, and your veterinary team is the best source of guidance for your dog's specific situation.

Regular rechecks allow your veterinarian to detect changes early and adjust treatment before the dog feels worse. Monitoring frequency depends on the stage and clinical stability:

• Stage 1: Approximately every 6 to 12 months, or as your vet advises
• Stage 2: Approximately every 3 to 6 months
• Stage 3: Approximately every 1 to 3 months
• Stage 4: Every 2 to 4 weeks, or more frequently if the dog is unstable

Your veterinarian will determine the right schedule based on your dog's trend, not just the stage label.

A typical recheck visit includes:

• Blood work — kidney values, electrolytes, phosphorus, packed cell volume
• Urinalysis and urine protein-to-creatinine ratio (UPC)
• Blood pressure measurement
• Weight and body condition assessment
• Review of appetite, hydration, and energy level at home

Tracking these values over time reveals whether the disease is stable, slowly progressing, or rapidly worsening — information that is far more useful than a single snapshot.

For more on kidney health support and monitoring, see kidney health.

This article is for informational purposes only and does not replace professional veterinary advice.

1. Renal Dysfunction in Small Animals — Merck Veterinary Manual
2. Kidney Disease in Dogs — VCA Animal Hospitals
3. IRIS Staging of CKD — International Renal Interest Society